TABLE 2

Effect of chronic compound-1 on plasma parameters in WD-fed MC4R KO mice

MiceWTWD-Fed MC4R KO
TreatmentVehicle (n = 5)Vehicle (n = 8)Compound-1
3 mg/kg (n = 8)10 mg/kg (n = 8)30 mg/kg (n = 8)
AST (IU/l)Pre41.8 ± 7.0636.9 ± 96.4$$$601.7 ± 108.6613.2 ± 101.7620.7 ± 92.3
Post64.3 ± 12.8649.6 ± 86.7526.4 ± 84.6268.9 ± 61.7¶¶105.3 ± 8.0¶¶
ALT (IU/l)Pre22.1 ± 4.6857.6 ± 103.9$$$849.5 ± 133.2860.2 ± 118.8858.9 ± 113.1
Post20.4 ± 14.1840.7 ± 124.4612.2 ± 94.2283.9 ± 74.0¶¶54.6 ± 9.1¶¶
TG (mg/dl)Pre132.0 ± 16.085.1 ± 15.9###88.2 ± 22.775.5 ± 15.181.7 ± 25.8
Post117.5 ± 39.675.2 ± 9.3132.0 ± 36.2¶¶146.0 ± 31.9¶¶159.3 ± 73.8¶¶
T-Cho (mg/dl)Pre95.5 ± 6.2405.5 ± 22.4$$$393.1 ± 38.3387.2 ± 26.6403.0 ± 31.3
Post97.0 ± 5.0429.2 ± 18.6390.4 ± 37.7*305.3 ± 37.2***164.8 ± 25.4***
  • Plasma parameters were measured before (Pre) and after (Post) 8 weeks of treatment.

  • Data are presented as the mean ± S.D. (n = 5–8).

  • ###P < 0.001 vs. vehicle-treated WT mice by Student’s t test; $P < 0.001 vs. vehicle-treated WT mice by Aspin–Welch test; *P < 0.05 and ***P < 0.001 vs. vehicle-treated WD-fed MC4R KO mice by Dunnett’s test; P < 0.05 and ¶¶P < 0.01 vs. vehicle-treated WD-fed MC4R KO mice by Steel’s test.